Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 283

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Spectrum of Steroid-Resistant and Congenital Nephrotic Syndrome in Children: The PodoNet Registry Cohort

Open access
Trautmann, Agnes, Bodria, Monica, Ozaltin, Fatih, Gheisari, Alaleh, Melk, Anette, Azocar, Marta, Anarat, Ali, Caliskan, Salim, Emma, Francesco, Gellermann, Jutta, Oh, Jun, Baskin, Esra, Ksiazek, Joanna, Remuzzi, Giuseppe, Erdogan, Ozlem, Akman, Sema, Dusek, Jiri, Davitaia, Tinatin, Özkaya, Ozan, Papachristou, Fotios, Firszt-Adamczyk, Agnieszka, Urasinski, Tomasz, Testa, Sara, Krmar, Rafael T., Hyla-Klekot, Lidia, Pasini, Andrea, Özcakar, Z. Birsin, Sallay, Peter, Cakar, Nilgun, Galanti, Monica, Terzic, Joelle, Aoun, Bilal, Caldas Afonso, Alberto, Szymanik-Grzelak, Hanna, Lipska, Beata S., Schnaidt, Sven, Schaefer, Franz·2015·Clinical Journal of the American Society of Nephrology

Abstract

BACKGROUND AND OBJECTIVES: Steroid-resistant nephrotic syndrome is a rare kidney disease involving either immune-mediated or genetic alterations of podocyte structure and function. The rare nature, heterogeneity, and slow evolution of the disorder are major obstacles to systematic genotype-phenotype, intervention, and outcome studies, hampering the development of evidence-based diagnostic and therapeutic concepts. To overcome these limitations, the PodoNet Consortium has created an international registry for congenital nephrotic syndrome and childhood-onset steroid-resistant nephrotic syndrome. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Since August of 2009, clinical, biochemical, genetic, and histopathologic information was collected both retrospectively and prospectively from 1655 patients with childhood-onset steroid-resistant nephrotic syndrome, congenital nephrotic syndrome, or persistent subnephrotic proteinuria of likely genetic origin at 67 centers in 21 countries through an online portal. RESULTS: Steroid-resistant nephrotic syndrome manifested in the first 5 years of life in 64% of the patients. Congenital nephrotic syndrome accounted for 6% of all patients. Extrarenal abnormalities were reported in 17% of patients. The most common histopathologic diagnoses were FSGS (56%), minimal change nephropathy (21%), and mesangioproliferative GN (12%). Mutation screening was performed in 1174 patients, and a genetic disease cause was identified in 23.6% of the screened patients. Among 14 genes with reported mutations, abnormalities in NPHS2 (n=138), WT1 (n=48), and NPHS1 (n=41) were most commonly identified. The proportion of patients with a genetic disease cause decreased with increasing manifestation age: from 66% in congenital nephrotic syndrome to 15%-16% in schoolchildren and adolescents. Among various intensified immunosuppressive therapy protocols, calcineurin inhibitors and rituximab yielded consistently high response rates, with 40%-45% of patients achieving complete remission. Confirmation of a genetic diagnosis but not the histopathologic disease type was strongly predictive of intensified immunosuppressive therapy responsiveness. Post-transplant disease recurrence was noted in 25.8% of patients without compared with 4.5% (n=4) of patients with a genetic diagnosis. CONCLUSIONS: The PodoNet cohort may serve as a source of reference for future clinical and genetic research in this rare but significant kidney disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2215/cjn.06260614

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 283

Metadata

Authors
Trautmann, A., Bodria, M., Ozaltin, F., Gheisari, A., Melk, A., Azocar, M., Anarat, A., Caliskan, S., Emma, F., Gellermann, J., Oh, J., Baskin, E., Ksiazek, J., Remuzzi, G., Erdogan, O., Akman, S., Dusek, J., Davitaia, T., Özkaya, O., Papachristou, F., Firszt-Adamczyk, A., Urasinski, T., Testa, S., Krmar, R. T., Hyla-Klekot, L., Pasini, A., Özcakar, Z. B., Sallay, P., Cakar, N., Galanti, M., Terzic, J., Aoun, B., Caldas Afonso, A., Szymanik-Grzelak, H., Lipska, B. S., Schnaidt, S., & Schaefer, F.
Venue
Clinical Journal of the American Society of Nephrology
Published
2015-04
Volume
10
Issue
4
Pages
592-600
ISSN
1555-9041 (ISSN-L)
OpenAlex
W2098823303
Cited by
283
References
11
FWCI
21.45
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spectrum of Steroid-Resistant and Congenital Nephrotic Syndrome in Children: The PodoNet Registry Cohort. https://app.cochat.ai/papers/10.2215/cjn.06260614
The paper
Trautmann, A., Bodria, M., Ozaltin, F., Gheisari, A., Melk, A., Azocar, M., Anarat, A., Caliskan, S., Emma, F., Gellermann, J., Oh, J., Baskin, E., Ksiazek, J., Remuzzi, G., Erdogan, O., Akman, S., Dusek, J., Davitaia, T., Özkaya, O., . . . Schaefer, F. (2015). Spectrum of Steroid-Resistant and Congenital Nephrotic Syndrome in Children: The PodoNet Registry Cohort. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.06260614

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.